XML 84 R74.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Segment research and development expense:        
Research and development $ 144,282 $ 290,059 $ 306,921 $ 613,635 [1]
Operating expenses not allocated to segments abstract        
Stock-based compensation     134,474 1,259,336
Depreciation and amortization     36,610 17,968
Asset impairment     1,800  
Loss from operations (184,151) (647,779) (399,896) (1,323,150) [1]
CODM [Member]        
Revenue:        
Revenues 80,568 144,618 [2] 161,270 313,023 [2]
Segment research and development expense:        
Research and development 86,611 64,391 [2] 185,700 113,319 [2]
Segment general and administrative expense:        
Segment general and administrative expense 67,606 49,010 [2] 143,254 88,938 [2]
Segment operating income (loss):        
Total segment operating income (loss) (91,745) (32,694) [2] (208,155) (38,577) [2]
Operating expenses not allocated to segments abstract        
Stock-based compensation [3] 62,477 607,270 [2] 137,677 1,266,305 [2]
Depreciation and amortization 17,652 9,028 [2] 36,610 17,968 [2]
Asset impairment 9,001 0 [2] 9,001 0 [2]
Change in fair value of contingent consideration liability 3,276 (1,213) [2] 8,453 300 [2]
Loss from operations (184,151) (647,779) [2] (399,896) (1,323,150) [2]
Biosecurity | CODM [Member]        
Revenue:        
Revenues 35,285 100,376 [2] 81,891 247,293 [2]
Segment cost of revenue:        
Cost of revenue 18,096 63,911 [2] 40,471 149,343 [2]
Segment research and development expense:        
Research and development 528 443 [2] 1,095 960 [2]
Segment general and administrative expense:        
Segment general and administrative expense 16,699 12,409 [2] 30,655 25,644 [2]
Segment operating income (loss):        
Total segment operating income (loss) (38) 23,613 [2] 9,670 71,346 [2]
Cell Engineering revenue [Member] | CODM [Member]        
Revenue:        
Revenues 45,283 44,242 [2] 79,379 65,730 [2]
Segment research and development expense:        
Research and development 86,083 63,948 [2] 184,605 112,359 [2]
Segment general and administrative expense:        
Segment general and administrative expense 50,907 36,601 [2] 112,599 63,294 [2]
Segment operating income (loss):        
Total segment operating income (loss) $ (91,707) $ (56,307) [2] $ (217,825) $ (109,923) [2]
[1] As adjusted to reflect the impact of the adoption of Accounting Standards Codification Topic 842, Leases (“ASC 842”) as of January 1, 2022. See Note 1 for a summary of the adjustments.
[2]

* As adjusted to reflect the impact of the adoption of ASC 842 as of January 1, 2022. See Note 1 for a summary of the adjustments.

[3]

(1) Includes $1.0 million and $0.8 million in employer payroll taxes for the three months ended June 30, 2023 and 2022, respectively, and $3.2 million and $7.0 million in employer payroll taxes for the six months ended June 30, 2023 and 2022, respectively.